Kidney

New clinical data on the experimental drug Tegoprubart show promising results in maintaining kidney transplant function and reducing side effects over two years, earning the therapy FDA Fast Track designation.

Early Wednesday, a complex cross-transplant operation between Israel and Cyprus concluded successfully. Three pairs of donors and recipients received life-saving kidneys through international coordination.